AI Identifies Environmental Chemicals with Highest Potential Health Risks

Artificial intelligence is accelerating the identification of chemical exposures across environmental media and within the human body. Yet simply detecting more molecules is not enough to explain why some exposures translate into disease risk. A new perspective reframes the goal of chemical exposomics: the central challenge is to determine which measured exposures are most likely to perturb biological systems and drive pathogenic pathways.

Published in Artificial Intelligence & Environment, the article argues for a shift toward “functional chemical exposomics.” This emerging paradigm combines high-resolution mass spectrometry, machine-learning models, toxicology knowledge bases, and biological response data. Together, these inputs aim to move from chemical inventories toward predictions of biological impact.

Exposomics studies the total spectrum of environmental chemicals encountered over a lifetime. Modern analytical platforms can generate thousands of signals from blood, urine, tissues, and environmental samples. However, many features remain unidentified, while the biological relevance of others is difficult to interpret using conventional toxicology alone.

The authors propose transforming AI from a discovery tool into a functional prediction engine. In practice, models would integrate chemical structure information with toxicity forecasts, molecular interaction patterns, and downstream changes in genes, proteins, and metabolites. Each candidate exposure could be assigned an activity-risk score, enabling researchers to prioritize which signals deserve costly laboratory validation.

A key element of the proposed workflow is causal inference. Because exposure–outcome associations in observational data can be confounded, machine-learning methods designed for causal questions may help separate meaningful biological effects from spurious correlations.

The framework also highlights mixture complexity, where multiple co-occurring chemicals may produce additive, synergistic, or antagonistic effects. Addressing this requires models that can learn from heterogeneous datasets and account for the uncertainty introduced by incomplete chemical annotation.

Despite the promise, the article emphasizes ongoing obstacles: limited high-quality training datasets, unobserved confounding factors, and the need for transparent, interpretable predictions. Ultimately, experimental verification—using cell systems, organoids, or animal models—remains essential for confirming model-driven hypotheses.

The perspective concludes that progress depends on cross-disciplinary collaboration among chemists, toxicologists, epidemiologists, bioinformaticians, and computer scientists. By turning exposomics into a predictive and preventive capability, AI could support more targeted public health interventions rather than broad, undifferentiated chemical monitoring.

Keywords

Artificial intelligence; machine learning; chemical exposomics; mass spectrometry; toxicity prediction; causal inference; biological response